These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 8707954

  • 1. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
    Shiina H, Igawa M, Urakami S, Honda S, Shirakawa H, Ishibe T.
    J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
    Shiina H, Igawa M, Yagi H, Urakami S, Shirakawa H, Ishibe T.
    Eur Urol; 1996 May; 30(1):80-8. PubMed ID: 8854073
    [Abstract] [Full Text] [Related]

  • 4. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
    Nakopoulou L, Vourlakou C, Zervas A, Tzonou A, Gakiopoulou H, Dimopoulos MA.
    Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
    Chaudhary KS, Lu QL, Abel PD, Khandan-Nia N, Shoma AM, el Baz M, Stamp GW, Lalani EN.
    Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H, Igawa M, Urakami S, Shirakawa H, Ishibe T.
    Urol Int; 1996 Jan; 56(3):163-8. PubMed ID: 8860737
    [Abstract] [Full Text] [Related]

  • 9. Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.
    Li B, Kanamaru H, Noriki S, Yamaguchi T, Fukuda M, Okada K.
    Urol Res; 1998 Jan; 26(4):235-41. PubMed ID: 9759996
    [Abstract] [Full Text] [Related]

  • 10. Variable Bcl-2 phenotype in benign and malignant lesions of urothelium.
    Bilim VN, Tomita Y, Kawasaki T, Takeda M, Takahashi K.
    Cancer Lett; 1998 Jun 05; 128(1):87-92. PubMed ID: 9652797
    [Abstract] [Full Text] [Related]

  • 11. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
    Skopelitou A, Hadjiyannakis M, Dimopoulos D, Kamina S, Krikoni O, Alexopoulou V, Rigas C, Agnantis NJ.
    Eur Urol; 1997 Jun 05; 31(4):464-71. PubMed ID: 9187909
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder.
    Uchida T, Minei S, Gao JP, Wang C, Satoh T, Baba S.
    Oncol Rep; 2002 Jun 05; 9(2):253-9. PubMed ID: 11836589
    [Abstract] [Full Text] [Related]

  • 14. p53 and bcl-2 overexpression as associated risk factors in patients 40 years old or less with transitional cell carcinoma of the bladder.
    Asci R, Yildiz L, Sarikaya S, Buyukalpelli R, Yilmaz AF, Kandemir B.
    Urol Int; 2001 Jun 05; 67(1):34-40. PubMed ID: 11464113
    [Abstract] [Full Text] [Related]

  • 15. Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K, Tominaga S, Kawai T, Torikata C, Aurues T, Ikeda T.
    Virchows Arch; 1998 May 05; 432(5):445-50. PubMed ID: 9645444
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunohistochemistry of p53 protein in transitional-cell carcinoma of the bladder using an image analyzer.
    Shiina H, Igawa M, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T.
    Oncology; 1996 May 05; 53(3):233-40. PubMed ID: 8643227
    [Abstract] [Full Text] [Related]

  • 18. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
    Offner FA, Schäfer G, Hittmair A, Ofner D, Grünewald K, Weyrer K, Mattern D, Eberle J, Mikuz G, Feichtinger H.
    Verh Dtsch Ges Pathol; 1993 May 05; 77():241-6. PubMed ID: 7511289
    [Abstract] [Full Text] [Related]

  • 19. Expression of bcl-2 in bladder neoplasms is a cell lineage associated and p53-independent event.
    Lu QL, Laniado M, Abel PD, Stamp GW, Lalani EN.
    Mol Pathol; 1997 Feb 05; 50(1):28-33. PubMed ID: 9208811
    [Abstract] [Full Text] [Related]

  • 20. Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
    Ogura K, Fukuzawa S, Habuchi T, Ogawa O, Yoshida O.
    Int J Urol; 1997 Nov 05; 4(6):561-6. PubMed ID: 9477184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.